Active Ingredient (In Each Tablet)
Aspirin 81 mg (NSAID)
nonsteroidal anti-inflammatory drug
The following Structured Product Label (SPL) was submitted to the FDA by Bayer Healthcare Llc. for the product Bayer Aspirin Regimen Chewable (NDC 0280-2080). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, do not use, otc - ask doctor/pharmacist, stop use and ask a doctor if, otc - pregnancy or breast feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Aspirin 81 mg (NSAID)
nonsteroidal anti-inflammatory drug
Pain reliever
Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness.
Allergy alert: Aspirin may cause a severe allergic reaction which may include:
Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you
Ask a doctor or pharmacist before use if you are taking a prescription drug for
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use aspirin during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
colloidal silicon dioxide, corn starch, dextrose, FD&C yellow #6 aluminum lake, flavor, microcrystalline cellulose, saccharin sodium
Questions or comments? 1-800-331-4536 (Mon-Fri 9AM – 5PM EST)
* Please review the disclaimer below.